Aligos Therapeutics Inc. (ALGS)
NASDAQ · Healthcare
Aligos Therapeutics Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aligos Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 35.0M, a 64.68% decrease year-over-year.
- Aligos Therapeutics Inc. total liabilities for 2025 were 35.0M, a 64.68% decrease from 2024.
- Aligos Therapeutics Inc. total liabilities for 2024 were 99.1M, a 66.65% increase from 2023.
- Aligos Therapeutics Inc. total liabilities for 2023 were 59.4M, a 38.92% increase from 2022.
- Aligos Therapeutics Inc. total liabilities for 2022 were 42.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aligos Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $35 |
| 2024 | $99 |
| 2023 | $59 |
| 2022 | $43 |
| 2021 | $51 |
| 2020 | $45 |
| Aligos Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $35 |
| 2024-12-31 | $99 |
| 2023-12-31 | $59 |
| 2022-12-31 | $43 |
| 2021-12-31 | $51 |
| 2020-12-31 | $45 |
Aligos Therapeutics Inc. Total Liabilities — FAQ
Aligos Therapeutics Inc. (ALGS) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALGS's total liabilities history?
The chart and table above show Aligos Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.